Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech High Insider Buying

Header cover image

Hong Kong Pharmaceuticals & Biotech High Insider Buying

UPDATED Jun 17, 2024

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

12 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	1177 Sino Biopharmaceutical	HK$2.75	1.1%	-25.9%	HK$50.4b	HK$4.58	PE25.4x	E14.3%	1.8%
	867 China Medical System Holdings	HK$7.04	-0.3%	-45.5%	HK$17.2b	HK$10.90	PE6.6x	E6.8%	6.0%
	512 Grand Pharmaceutical Group	HK$4.86	0.8%	9.2%	HK$16.7b	n/a	PE9.1x	E13.9%	5.3%
	2005 SSY Group	HK$4.75	1.9%	-7.4%	HK$14.0b	HK$6.23	PE10.7x	E15.0%	3.6%
	6660 AIM Vaccine	HK$6.96	-1.4%	-84.7%	HK$8.4b	HK$53.03	PS6.6x	S56.4%	n/a
	2171 CARsgen Therapeutics Holdings	HK$5.42	-2.3%	-49.1%	HK$3.4b	HK$7.20	PB1.6x	E20.4%	n/a
	2256 Abbisko Cayman	HK$3.05	4.8%	9.7%	HK$2.0b	HK$8.69	PS96.3x	E-32.5%	n/a
	3737 Zhongzhi Pharmaceutical Holdings	HK$1.12	14.3%	3.7%	HK$906.8m	n/a	PE5.5x	n/a	5.3%
	1652 Fusen Pharmaceutical	HK$1.17	-0.8%	-10.0%	HK$865.0m	n/a	PS1.4x	n/a	0%
	950 Lee's Pharmaceutical Holdings	HK$1.22	0.8%	-18.7%	HK$671.3m	HK$1.00	PE43x	S16.1%	1.5%
	6628 Transcenta Holding	HK$1.34	-19.3%	-74.7%	HK$571.1m	HK$8.69	PS9.4x	E10.0%	n/a
	1889 Sanai Health Industry Group	HK$0.022	-15.4%	-69.0%	HK$80.3m	n/a	PE4.2x	n/a	0%

Page 1 of 1